(Q40602894)
Statements
Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma (English)
M Duvic
A G Martin
Y Kim
E Olsen
G S Wood
C A Crowley
R C Yocum
Worldwide Bexarotene Study Group